We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.6M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.94M
3
CZR icon
Caesars Entertainment
CZR
+$3.71M
4
IAA
IAA, Inc. Common Stock
IAA
+$3.57M
5
RUN icon
Sunrun
RUN
+$3.42M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.2M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$15.9M
3
MSFT icon
Microsoft
MSFT
+$13.6M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$9.6M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.15M

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRCE icon
1751
1st Source
SRCE
$2.14B
$241K ﹤0.01%
7,814
– –
EBF icon
1752
Ennis
EBF
$556M
$241K ﹤0.01%
13,814
– –
BCRX icon
1753
BioCryst Pharmaceuticals
BCRX
$2.49B
$241K ﹤0.01%
70,081
– –
CRMT icon
1754
America's Car Mart
CRMT
$26.5M
$240K ﹤0.01%
2,826
– –
SRDX
1755
DELISTED
Surmodics
SRDX
$240K ﹤0.01%
6,159
– –
CMO
1756
DELISTED
Capstead Mortgage Corp.
CMO
$239K ﹤0.01%
42,582
– –
TBI
1757
Trueblue
TBI
$304M
$239K ﹤0.01%
15,422
– –
CARS icon
1758
Cars.com
CARS
$668M
$238K ﹤0.01%
29,503
– –
ATNI icon
1759
ATN International
ATNI
$493M
$238K ﹤0.01%
4,754
– –
OTRK
1760
DELISTED
Ontrak
OTRK
$238K ﹤0.01%
+44
New +$204K
XPEL icon
1761
XPEL
XPEL
$1.37B
$238K ﹤0.01%
9,125
– –
CSTL icon
1762
Castle Biosciences
CSTL
$945M
$237K ﹤0.01%
4,608
– –
RDUS
1763
DELISTED
Radius Health, Inc.
RDUS
$237K ﹤0.01%
20,884
– –
TCRR
1764
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$236K ﹤0.01%
11,591
+3,380
+41% +$59.3K
NARI
1765
DELISTED
Inari Medical, Inc. Common Stock
NARI
$235K ﹤0.01%
+3,408
New +$219K
VNDA icon
1766
Vanda Pharmaceuticals
VNDA
$305M
$235K ﹤0.01%
24,336
– –
GES
1767
DELISTED
Guess Inc
GES
$235K ﹤0.01%
20,227
– –
IMKTA icon
1768
Ingles Markets
IMKTA
$1.67B
$235K ﹤0.01%
6,173
– –
MCRI icon
1769
Monarch Casino & Resort
MCRI
$2.2B
$235K ﹤0.01%
5,265
– –
MDP
1770
DELISTED
Meredith Corporation
MDP
$234K ﹤0.01%
17,831
– –
BOOM icon
1771
DMC Global
BOOM
$154M
$234K ﹤0.01%
7,096
– –
BMTC
1772
DELISTED
Bryn Mawr Bank Corp
BMTC
$233K ﹤0.01%
9,382
– –
DNOW icon
1773
DNOW Inc
DNOW
$2.95B
$233K ﹤0.01%
51,271
– –
EFC
1774
Ellington Financial
EFC
$1.77B
$233K ﹤0.01%
18,985
– –
BRKL
1775
DELISTED
Brookline Bancorp
BRKL
$232K ﹤0.01%
26,891
-9,751
-27% -$92.7K
69 70
71
72 73

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.